Marla Lay
Impact in
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Blood Coagulation and Thrombosis Mechanisms
Papers in
-
- Advanced biosensing and bioanalysis techniques 2
- Molecular Biology Techniques and Applications 2
-
- Blood Coagulation and Thrombosis Mechanisms 4
- Hemophilia Treatment and Research 2
- Co-authors
- Carl T. Wittwer (3 shared papers)James L. Zehnder (9 shared papers)Philip S. Bernard (1 shared paper)Jason Gotlib (2 shared papers)Carol D. Jones (2 shared papers)Malaiyalam Mariappan (2 shared papers)Irving L. Weissman (1 shared paper)Jeffrey A. Durocher (1 shared paper)
- Journals
- American Journal of Clinical Pathology (3 papers)Journal of Molecular Diagnostics (2 papers)Clinical and Vaccine Immunology (1 paper)Cancer Biology & Therapy (1 paper)Clinical Chemistry (1 paper)
- Partner nations
- United States
In The Last Decade
Marla Lay
16 papers receiving 700 citations
Peers
Comparison fields: 5 of 79
- Genetics 235
- Hematology 235
- Rheumatology 120
- Internal Medicine 22
- Molecular Biology 391
Countries citing papers authored by Marla Lay
This map shows the geographic impact of Marla Lay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marla Lay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marla Lay more than expected).
Fields of papers citing papers by Marla Lay
This network shows the impact of papers produced by Marla Lay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marla Lay. The network helps show where Marla Lay may publish in the future.
Co-authors
The 25 scholars most cited alongside Marla Lay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 232 | |
| 2 | 2006 | 208 | |
| 3 | 1998 | 105 | |
| 4 | 2009 | 43 | |
| 5 | 2006 | 22 | |
| 6 | 2009 | 19 | |
| 7 | 2007 | 18 | |
| 8 | 2003 | 18 | |
| 9 | 2003 | 16 | |
| 10 | 2008 | 13 | |
| 11 | 2004 | 10 | |
| 12 | 2005 | 7 | |
| 13 | 1999 | 5 | |
| 14 | 2010 | 4 | |
| 15 | 2003 | 1 | |
| 16 | 2004 | 1 |
About Marla Lay
Marla Lay is a scholar working on Molecular Biology, Hematology, Immunology, Epidemiology and Genetics, having authored 16 papers that have together received 722 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Hemophilia Treatment and Research (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Connective tissue disorders research (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Molecular Biology Techniques and Applications (2 papers) and Protease and Inhibitor Mechanisms (2 papers). The work is most often cited by research in Genetics (235 citations), Hematology (235 citations), Rheumatology (120 citations), Internal Medicine (22 citations) and Molecular Biology (391 citations). Marla Lay has collaborated with scholars based in United States. Frequent co-authors include Carl T. Wittwer, James L. Zehnder, Philip S. Bernard, Jason Gotlib, Carol D. Jones, Malaiyalam Mariappan, Irving L. Weissman, Jeffrey A. Durocher, Catriona Jamieson and Mark P. Chao. Their work appears in journals such as American Journal of Clinical Pathology, Journal of Molecular Diagnostics, Clinical and Vaccine Immunology, Cancer Biology & Therapy and Clinical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.